Kyorin Holdings Inc
TSE:4569
Kyorin Holdings Inc
TSE:4569
Price:
1 753 JPY
-4.16%
Updated:
May 14, 2024
P/E
Price to Earnings
Price to Earnings
23.6
Current
23.3
Median
23.4
Industry
Higher
than median
Higher
than industry value
Price to Earnings (P/E) ratio is a valuation multiple that compares a company’s market capitalization to its net income. It indicates the dollar amount an investor can expect to invest in a company in order to receive $1 of that company’s earnings.
P/E
=23.6
Market Cap
/
100.7B
Net Income
4.3B
All Countries
| Market Cap | P/E | ||||
|---|---|---|---|---|---|
| JP |
|
Kyorin Holdings Inc
TSE:4569
|
100.7B JPY | 23.6 | |
| JP |
N
|
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
|
776 550.9T JPY | -5 347 888.9 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
720.1B USD | 117.3 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
4.1T DKK | 46 | |
| UK |
|
Dechra Pharmaceuticals PLC
LSE:DPH
|
440.4B GBP | -15 783.5 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
363.9B USD | 9.5 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
327.5B USD | 142 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
191.2B GBP | 37.9 | |
| CH |
|
Novartis AG
SIX:NOVN
|
182B CHF | 11.4 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
177.8B CHF | 15.5 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
160.6B USD | -519.7 |
P/E Forward Multiples
Forward P/E multiple is a version of the P/E ratio that uses forecasted net income for the P/E calculation. 1-Year, 2-Years, and 3-Years forwards use net income forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
P/E
18.5
2-Years Forward
P/E
16.8
3-Years Forward
P/E
21.1
You don't have any saved screeners yet
